CZS Breakthroughs: Life Science Technologies – Synthetics
The Carl Zeiss Stiftung has published a new call "CZS breakthroughs: Synthetics" (focus area: Life Science Technologies). With the ‘CZS breakthroughs’ funding programme, the Carl-Zeiss-Stiftung is enabling universities to implement innovative, scientifically promising concepts. Projects that receive funding are intended to lead to internationally competitive research results. The call for applications ‘CZS breakthroughs: Synthetics’ focuses on research into the design of bio-based systems. The growing understanding of biology makes it possible to reproduce and adapt them. To that end, engineering approaches to design and construction are applied to biological systems. Accordingly, the call for applications should promote research that addresses those developments. For example, the interdisciplinary research projects unite molecular biology, biochemistry, biotechnology or genetic methods with engineering and IT. The research projects can pursue the following and other objectives: Adapting, designing, and synthesising organic molecules, biological components or systems; developing paradigms for treating illnesses; developing new biological production methods. Possible topics include organoids and artificial organs, synthetic biology, regenerative medicine, and gene und cell therapy. The projects should create a connection between life sciences and engineering and advance personalised medicine through the development of new life science technologies.
Funding can be requested for up to 5.000.000 Euro for 5-6 years.
The University of Tübingen can only hand in one proposal.
Proposals thus have to be handed in in agreement with the President's Office. Expressions of interest have to be submitted until January 23rd to nathalie.walker@uni-tuebingen.de Expressions of interest must include:
-
short description of the proposal (1-2 pages)
- rough financial plan
- CVs of all participants (max. 2 pages per CV)